T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Amazon
AMZN
|
+$3.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.02B |
| 3 |
EQT Corp
EQT
|
+$1.52B |
| 4 |
Adobe
ADBE
|
+$1.29B |
| 5 |
Constellation Energy
CEG
|
+$1.16B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.09B |
| 2 |
UnitedHealth
UNH
|
+$1.75B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.69B |
| 4 |
Ross Stores
ROST
|
+$1.64B |
| 5 |
ASML
ASML
|
+$1.59B |
Sector Composition
| 1 | Technology | 31.66% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
IAC Inc
IAC
$2.92B
| $164M | 0.02% |
3,192,612
-17,543
| -0.5% | -$904K |
|
427
Bank of New York Mellon
BK
$73.9B
| $163M | 0.02% |
3,666,448
+2,235,409
| +156% | +$99.5M |
|
428
Fair Isaac
FICO
$36.9B
| $163M | 0.02% |
201,707
+31,191
| +18% | +$25.2M |
|
429
Ventas
VTR
$30.9B
| $163M | 0.02% |
3,445,840
-47,086
| -1% | -$2.23M |
|
430
Bunge Global
BG
$16.9B
| $162M | 0.02% |
1,720,074
-171,750
| -9% | -$16.2M |
|
431
Peloton Interactive
PTON
$3.24B
| $161M | 0.02% |
20,910,838
-19,538,863
| -48% | -$150M |
|
432
Scholastic
SCHL
$670M
| $158M | 0.02% |
4,075,166
-189,854
| -4% | -$7.38M |
|
433
Dover
DOV
$24.4B
| $158M | 0.02% |
1,073,355
-1,103,709
| -51% | -$163M |
|
434
Ionis Pharmaceuticals
IONS
$10.3B
| $157M | 0.02% |
3,835,867
-99,084
| -3% | -$4.07M |
|
435
Mettler-Toledo International
MTD
$27.1B
| $155M | 0.02% |
118,011
-183,203
| -61% | -$240M |
|
436
Akero Therapeutics
AKRO
$3.57B
| $154M | 0.02% |
3,289,643
+665,963
| +25% | +$31.1M |
|
437
Super Micro Computer
SMCI
$25.5B
| $153M | 0.02% |
6,158,250
+5,928,480
| +2,580% | +$148M |
|
|
AIV
438
Aimco
AIV
$1.1B
| $153M | 0.02% |
17,946,816
-6,125
| -0% | -$52.2K |
|
439
Bruker
BRKR
$4.73B
| $151M | 0.02% |
2,046,315
-637,454
| -24% | -$47.1M |
|
440
Guardant Health
GH
$7.41B
| $151M | 0.02% |
4,215,380
+2,532,687
| +151% | +$90.7M |
|
441
Zscaler
ZS
$43.8B
| $150M | 0.02% |
1,022,577
+537,081
| +111% | +$78.6M |
|
442
International Flavors & Fragrances
IFF
$17B
| $149M | 0.02% |
1,874,904
-2,701,124
| -59% | -$215M |
|
443
10x Genomics
TXG
$1.68B
| $148M | 0.02% |
2,657,324
+243,364
| +10% | +$13.6M |
|
444
NOV
NOV
$4.92B
| $148M | 0.02% |
9,225,202
-741,596
| -7% | -$11.9M |
|
445
Raymond James Financial
RJF
$33B
| $148M | 0.02% |
1,421,484
+82,139
| +6% | +$8.52M |
|
446
Atmos Energy
ATO
$26.3B
| $147M | 0.02% |
1,266,139
-112,947
| -8% | -$13.1M |
|
447
Aptiv
APTV
$17.9B
| $147M | 0.02% |
1,439,022
-1,284,962
| -47% | -$131M |
|
448
Moderna
MRNA
$9.52B
| $146M | 0.02% |
1,201,434
-411,017
| -25% | -$49.9M |
|
449
Verra Mobility
VRRM
$3.9B
| $146M | 0.02% |
7,390,368
+7,183,887
| +3,479% | +$142M |
|
450
Immunocore
IMCR
$1.85B
| $145M | 0.02% |
2,423,420
+1,039,980
| +75% | +$62.4M |
|